Search Results - Edward Garmey

618 Phase 1 clinical trial evaluating the safety, biologic and anti-tumor activity of the novel STING agonist IMSA101 administered both as monotherapy and in combination with PD-(L... by Syed Kazmi, Lijun Sun, Angela Alistar, Ezra Cohen, Timothy Yap, Devalingam Mahalingam, Justin C Moser, Edward Garmey, Teresa Mooneyham

Phase 1 first-in-human dose-escalation study of IMSA101, a novel cyclic di-nucleotide STING agonist, for patients with advanced solid tumor malignancies by Syed Kazmi, Lijun Sun, Justin Moser, Angela Alistar, Timothy A Yap, Edward Garmey, Teresa Mooneyham, Peter Vu, Jay Jacoby, Deva Mahalingam

Get full text

1380 Non-clinical results and design of first-in-human study for GIGA-564, a third-generation anti-CTLA-4 monoclonal antibody by James L Gulley, Rong Deng, Carl Millward, Jason M Redman, Yao Chiang, Ariel Niedecken, Kacy Stadtmiller, Edward Garmey, Vincent Poon, Michael A Asensio, Janice Lansita, Kyle P Carter, Ellen K Wagner, Erica L Stone